Pharm MSK Flashcards

1
Q

Synthesis of ACh

A

1) Choline transport via Choline transporter

2) Choline Acyltransferase: produces ACh via Choline and Acetyl-CoA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Storage of ACh

A

1) ACh into the vesicle via ACh vesicular transporter

2) ATP-dependent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ACh release

A

1) Action potential triggers Voltage Gated Ca2+ channels
2) Ca2+ enters cell –> promote fusion of vesicles via Synaptoagmin
3) VAMPs and SNAPs initiate vesicle fusion and release of ACh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

VAMPs

A

Synaptobrevin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

SNAPs

A

SNAP-25 and Syntaxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What prevents SNAP-25 and Syntaxin complex formation

A

N-Sec-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What associates with SNAP-25 and Syntaxin complex to form a Ternary

A

Synaptobrevin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What allows for recycling of vesicle

A

NSF (ATPase) + SNAP bind and hydrolysisze ATP–> ADP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ACh action termination

A

1) Acetylcholinesterase: ACh –> Acetate and Choline
2) Acetate diffuses out of cleft
3) Choline recycled via choline transporter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Structure of nAChR

A

5 subunits surrounding a central pore w/ negative charge aa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Agents that affect nerve action potential

A

1) Tetrodotoxin

2) Local Anesthetics: Lidocaine, Bupivacaine, Procaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Local anesthetics are useful for what?

A

Pain control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Tetrodotoxin and Local anesthetics are agents that affects nerve action potential. What’s their MOA

A

Blocks voltage-gated Na+ channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What agents affect vesicular acetylcholine release

A

1) Botulinum Toxin

2) Tetanus Toxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Botulinum Toxin affects vesicular acetylcholine release. What is the MOA of Botulin Toxin

A

Cleaves SNAREs and prevents ACh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Tetanus Toxin is an agent that affects vesicular acetylcholine release. What’s its MOA

A

1) Targets Synaptobrevin of inhibitory neurons of spinal cord

17
Q

Spastic Paralysis and Lock jaw are common synptoms of what>

A

Tetanus Toxin

18
Q

Why is Botulinum Toxin Clinically Relevant?

A

1) Temporary improvement in lines and wrinkles of face

2) Prophylaxis of Chronic Migraine Headache

19
Q

What’s the class name of agents that affect depolarization

A

1) Neuromuscular Blocking Drugs

20
Q

Neuromuscular blocking drugs are drugs that affect depolarization. List some common drugs that are affected with this?

A

1) Curare Alkaloids (d-tubocurarine)

2) Succinylcholine

21
Q

Neuromuscular drugs can either be agonist or antagonist. Describe both.

A

1) Agonist: Activate nAChR and generate signal
- succinylcholine

2) Antagonist: Bind but dont activate
- d-tubocurarine

22
Q

What neuromuscular drug causes transient muscle fasciculation due to agonist activity

A

Succinylcholine

23
Q

How is Succinylcholine paralysis reversed?

A

Time

24
Q

How in d-tubocurarine paralysis reversed

A

Increasing ACh via acetylcholine esterase inhibitor

25
Q

Agents that affect hydrolysis of ACh by AChE

A

AChE inhibitors

26
Q

Clinical use of AChE inhibitors

A

1) Dementia associated w/ Alzzheimer’s or Parkinsons disease, myasthenia gravis
2) Nerve gas and organophosphate pesticide exposure
3) Reversal of neuromuscular blockade during anestheia

27
Q

Agents that affect muscular contraction

A

Dantrolene

28
Q

Dantrolene MOA

A

Inhibits ryanodine receptors in the SR and blocks the release of Ca2+

29
Q

Clinical use of Dantrolene

A

Malignant Hyperthermia, Spasticity associated w/ upper motor neuron disorders